Back to today’s briefing

Story perspectives

FDA Overhauls Regulations to Boost Domestic Drug Production

5/28/2025

33 7

Summary

Story summary

The FDA is transforming under the Trump administration, prioritizing the removal of regulatory hurdles and boosting domestic drug production. New executive orders are set to expedite facility approvals while tightening oversight on foreign manufacturers. This pivotal shift underscores the biopharma sector's vital role in safeguarding national security in the U.S.

1 of 1

Story summary

The FDA is transforming under the Trump administration, prioritizing the removal of regulatory hurdles and boosting domestic drug production. New executive orders are set to expedite facility approvals while tightening oversight on foreign manufacturers. This pivotal shift underscores the biopharma sector's vital role in safeguarding national security in the U.S.